Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
Clinical trial NCT03113071 · TERMINATED
Trial details
- NCT number
- NCT03113071
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2019-01-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.